Aims To determine the effect of the glucagon‐like peptide‐1 analogue liraglutide on left
ventricular function in chronic heart failure patients with and without type 2 diabetes …

Background: Myocardial utilization of 3-hydroxybutyrate (3-OHB) is increased in patients
with heart failure and reduced ejection fraction (HFrEF). However, the cardiovascular effects …

Background High levels of ketone bodies are associated with improved survival as observed
with regular exercise, caloric restriction, and—most recently—treatment with sodium …

Background The use of β-adrenergic receptor blocking agents in symptomatic patients with
obstructive hypertrophic cardiomyopathy (HCM) rests on clinical experience and …

The incretin hormone glucagon-like peptide-1 (GLP-1) and its analogs are currently
emerging as antidiabetic medications. GLP-1 improves left ventricular ejection fraction …

Transfer of full-length genes including regulatory elements has been the preferred gene
therapy strategy for clinical applications. However, with significant drawbacks emerging …

Background The relationship between exercise hemodynamics, loading conditions, and
medical treatment in patients with obstructive hypertrophic cardiomyopathy (HCM) is …

Myocardial deformation assessed by speckle tracking echocardiography (STE) is
increasingly used for diagnosis, monitoring and prognosis in patients with clinical and pre …

Abstract The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output and
myocardial perfusion without affecting blood pressure in humans, but the cardiovascular …

Remote ischemic conditioning (RIC) protects against acute ischemia–reperfusion injury and
may also have beneficial effects in patients with stable cardiovascular disease. We …